AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
172 hedge funds and large institutions have $2.33B invested in Aerie Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 70 increasing their positions, 53 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less call options, than puts
Call options by funds: $15.7M | Put options by funds: $21.5M
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Holders
172
Holding in Top 10
7
Calls
$15.7M
Puts
$21.5M
Top Buyers
| 1 | +$65.1M | |
| 2 | +$39.4M | |
| 3 | +$30.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$25M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$10.7M | |
| 3 | -$5.08M | |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$4.71M |
| 5 |
CCM
Copernicus Capital Management
San Francisco,
California
|
-$4.67M |